Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients - Wikidata - awgldk - TriplyDB

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients

http://www.wikidata.org/entity/Q36644668

about

Pharmacological treatments for fatigue associated with palliative care Carnitine for fatigue in multiple sclerosis Carnitine for fatigue in multiple sclerosis Fatigue Management in Multiple Sclerosis Micronutrients in Oncological Intervention L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study.Evaluation and management of fatigue in oncology: a multidimensional approach.Inhibition of gene expression of organic cation/carnitine transporter and antioxidant enzymes in oxazaphosphorines-induced acute cardiomyopathic rat models.Associations of subjective vitality with DNA damage, cardiovascular risk factors and physical performance.L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial.A critical review of complementary therapies for cancer-related fatigue.l-carnitine and cancer cachexia: Clinical and experimental aspects.A review of the logistic role of L-carnitine in the management of radiation toxicity and radiotherapy side effects.Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.Potential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literature.Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.Screening, evaluation, and management of cancer-related fatigue: Ready for implementation to practice?A cross-sectional study of carnitine deficiency and fatigue in pediatric cancer patients.L-carnitine has a protective effect on the colonic mucosa during abdominopelvic radiotherapy in rats.Integrative healthcare symposium: cancer and chronic lyme disease.L-Carnitine induces recovery of liver lipid metabolism in cancer cachexia.Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis.Cats in Positive Energy Balance Have Lower Rates of Adipose Gain When Fed Diets Containing 188 versus 121 ppm L-Carnitine.Carnitine is associated with fatigue following chemoradiotherapy for head and neck cancer.

P2860

Q24187756-ECFDABD5-00F9-4782-8D2C-47F097ADAEA9 Q24197748-1B0CA7FE-B058-4A9E-AB4B-F6EAE50BE582 Q24240036-AD1816FF-D7FA-4084-A373-6C135341D019 Q26752946-BA1E6883-7799-40AB-925F-5E23DAA3A05B Q26764839-771E7671-DB41-4993-8B4E-B0D3BAB87040 Q35121171-098462D1-EB22-465C-9187-3EFA4EF0A011 Q35245106-9B7940DA-B172-4892-A9D0-A286D84060FC Q36014607-0C9A1F8F-66F1-4BD2-891F-FC88DFBE9E01 Q36100869-4AB73FA8-9683-4A07-8DED-D3CAFD4A950F Q36226621-C102138F-7029-4C1F-AA61-9A096EE355B7 Q36339712-5610631B-55EE-494F-AD8F-E977C9403E68 Q36757037-337BC049-5ABA-4E24-9730-28E23F62EA13 Q37863019-7805446A-03CA-4E3A-B71C-FE181922E2D2 Q37912089-005A7827-723E-4B55-85DA-3664A5544F3D Q38090981-06A969DF-495F-4B26-9A27-F55222C945B0 Q38105163-38F94DD1-943D-4D55-BB24-562A32DD4039 Q38130229-EBA9C856-9869-4BF5-8B0C-E025C8CF9472 Q38373602-11856A2D-9501-4E0E-9AF0-348E171FFB42 Q38915903-23563A6C-E5CB-46BA-91BD-9AF6FC2344DF Q39294896-CA52D406-6722-4DCD-A6C2-613BFEBABC85 Q41452535-D935BC74-3D00-42DC-9092-346185C571DC Q43493969-233D94E6-25EE-4C42-8B2F-214B201811D7 Q47103663-A9A20A20-5BE9-484D-AA2A-2AC8CFCCD897 Q51800422-77BC9FDA-2381-4F30-BD34-181AA091ACAA Q52954671-18F4E9AC-A110-4C23-BD53-EB2F9383B95E

P2860

Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients

http://www.wikidata.org/entity/Q36644668

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Potential role of levocarnitin ...... in non-anaemic cancer patients

@ast

Potential role of levocarnitin ...... in non-anaemic cancer patients

@en

type

label

Potential role of levocarnitin ...... in non-anaemic cancer patients

@ast

Potential role of levocarnitin ...... in non-anaemic cancer patients

@en

prefLabel

Potential role of levocarnitin ...... in non-anaemic cancer patients

@ast

Potential role of levocarnitin ...... in non-anaemic cancer patients

@en

P1433

Q36644668-AED6EC16-431F-439D-B254-5D1B88E937FD

P1476

Q36644668-88D972BC-F4C0-46CA-BA88-022A0F3FE274

P2093

Q36644668-1E868B3A-5CA8-4AE6-87DE-05191DB0C4EE

Q36644668-49895A00-886A-4BC8-B787-A33B162D1299

Q36644668-57C86F6C-ACA8-4781-BC77-201C6954EC98

Q36644668-608EEC91-0810-4D1B-BC42-201D3926EB6E

Q36644668-6B53BDE6-6943-4C8E-A0BF-979DDBF31F47

Q36644668-6BF037E0-C55B-4A49-8D60-52608924A432

Q36644668-7A68DCAB-4907-49C0-A4AB-522D4BF96064

Q36644668-7FBDFF70-C421-45B6-BD5B-3F723C62CC6A

Q36644668-858E0D50-C78F-47E6-8275-1AF2BA5482BD

Q36644668-AC7C4F47-0A57-4F3D-B32E-73163DA6917C

P2860

Q36644668-08B328C6-7B27-4118-A9EE-21F0FA335936

Q36644668-10E2D183-9E33-4FDB-B8FA-0697EB323587

Q36644668-1F9092C5-0467-4175-887A-883C8077A2B1

Q36644668-34D1F2D0-02A0-4550-A627-34F31EF78C91

Q36644668-356F9ECE-CDD2-417D-8EBF-D851CE0EB09B

Q36644668-60DDE3DA-1D4E-4738-BB0E-35C0C9646242

Q36644668-68D60684-80A6-4C57-9C24-D8DE93C10BED

Q36644668-6EC6AF7B-BAF4-4D60-953F-C8192F47A45D

Q36644668-7EA544A8-0B6F-4E88-B6AA-A0FB64077ED4

Q36644668-9AAE23B6-6BE8-4FB8-B9CF-9D3FAD639527

P2888

Q36644668-FCE2E49C-A66F-43A2-9667-69DEE8C12128

P304

Q36644668-51B870EF-100D-4E67-BAFE-0E3C7AD6ED85

P31

Q36644668-E3016904-4ADE-48E4-AC82-2BC9401F4B42

P356

Q36644668-B641C142-768F-4D8F-9AE3-2691309825E4

P407

Q36644668-5318C310-F82F-40ED-871D-850E24407CAB

P433

Q36644668-5641D424-EA42-494A-961C-6BB3C6626A48

P478

Q36644668-79915E72-7BEC-4F24-9154-44E2EF0DA1ED

P577

Q36644668-CBBEA7FD-9EEF-469C-A8E5-E6A31452D603

P5875

Q36644668-2C0F9636-7BCA-47BE-8552-36F15BF5AD2C

P698

Q36644668-B26FA801-01D4-4788-A1D8-33B1D2826F46

P921

Q36644668-8CF659E2-0231-48A2-BEEA-23F1A8CDE6D5

P932

Q36644668-DB769266-B4D7-413B-8952-E88379A724B2

P356

P1433

British Journal of Cancer

P1476

Potential role of levocarnitin ...... in non-anaemic cancer patients

@en

P2093

A De Gaetano

http://www.w3.org/2001/XMLSchema#string

A M Baldelli

http://www.w3.org/2001/XMLSchema#string

B Ferraro

http://www.w3.org/2001/XMLSchema#string

E Mencarini

http://www.w3.org/2001/XMLSchema#string

E Testa

http://www.w3.org/2001/XMLSchema#string

F Canestrari

http://www.w3.org/2001/XMLSchema#string

F Graziano

http://www.w3.org/2001/XMLSchema#string

P Giordani

http://www.w3.org/2001/XMLSchema#string

R Bisonni

http://www.w3.org/2001/XMLSchema#string

R Silva

http://www.w3.org/2001/XMLSchema#string

P2860

Determination of L-carnitine in biological fluids and tissues

Cancer-related fatigue: guidelines for evaluation and management.

Chemotherapy-induced anemia in adults: incidence and treatment.

Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system.

Biology of cachexia.

Effect of carnitine on muscular glutamate uptake and intramuscular glutathione in malignant diseases.

Alterations of serum and urinary carnitine profiles in cancer patients: hypothesis of possible significance.

Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.

Cancer fatigue: one drug fails but more are in the pipeline.

Improved methodology to assay carnitine and levels of free and total carnitine in human plasma.

P2888

P304

1854-1857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6600413

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11290525

http://www.w3.org/2001/XMLSchema#string

P698

12085175

http://www.w3.org/2001/XMLSchema#string

P921

P932

2375434

http://www.w3.org/2001/XMLSchema#string